Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Investigation of Drug-Drug Interactions Caused by Human Pregnane X Receptor-Mediated Induction of CYP3A4 and CYP2C Subfamilies in Chimeric Mice with a Humanized Liver

Maki Hasegawa, Harunobu Tahara, Ryo Inoue, Masakazu Kakuni, Chise Tateno and Junko Ushiki
Drug Metabolism and Disposition March 2012, 40 (3) 474-480; DOI: https://doi.org/10.1124/dmd.111.042754
Maki Hasegawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harunobu Tahara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryo Inoue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masakazu Kakuni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chise Tateno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junko Ushiki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 40 no. 3 474-480
DOI 
https://doi.org/10.1124/dmd.111.042754
PubMed 
22126990

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received September 14, 2011
  • Accepted November 29, 2011
  • Published online February 15, 2012.

Article Versions

  • Earlier version (November 29, 2011 - 08:20).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Maki Hasegawa,
  2. Harunobu Tahara,
  3. Ryo Inoue,
  4. Masakazu Kakuni,
  5. Chise Tateno and
  6. Junko Ushiki
  1. Kyowa Hakko Kirin Co., Ltd., Nagaizumi-cho, Sunto-gun, Shizuoka, Japan (M.H., H.T., J.U.); and PhoenixBio, Co., Ltd., Higashihiroshima-shi, Hiroshima, Japan (R.I., M.K., C.T.)
  1. Address correspondence to:
    Dr. Maki Hasegawa, Kyowa Hakko Kirin Co., Ltd., 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8731, Japan. E-mail: maki.hasegawa{at}kyowa-kirin.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to August 2022

AbstractFullPdf
Aug 201742821
Sep 20171236
Oct 201723410
Nov 20170178
Dec 201712412
Jan 201801211
Feb 201833112
Mar 20181258
Apr 20182246
May 201803010
Jun 20181367
Jul 20180115
Aug 20181126
Sep 20180236
Oct 20183128
Nov 201802612
Dec 201810119
Jan 20193423
Feb 20192067
Mar 20193134
Apr 20194549
May 20194457
Jun 20195526
Jul 20196843
Aug 20198755
Oct 20191902
Nov 20192735
Dec 201937410
Jan 20202538
Feb 20201774
Mar 202020316
May 20201343
Jun 20201811
Jul 2020903
Aug 2020501
Sep 2020841
Oct 20202574
Nov 20202124
Dec 20202122
Jan 202128511
Feb 20212574
Mar 20212122
Apr 20212443
May 20211264
Jun 20212363
Jul 20211444
Aug 20211446
Sep 20211183
Oct 2021631
Nov 20211967
Dec 20212886
Jan 2022931
Feb 20221111
Mar 20222234
Apr 20222495
May 20223668
Jun 20221943
Jul 202222120
Aug 20221811

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 40 (3)
Drug Metabolism and Disposition
Vol. 40, Issue 3
1 Mar 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Investigation of Drug-Drug Interactions Caused by Human Pregnane X Receptor-Mediated Induction of CYP3A4 and CYP2C Subfamilies in Chimeric Mice with a Humanized Liver
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

INDUCTION OF CYP3A4 AND CYP2C SUBFAMILIES IN PXB MICE

Maki Hasegawa, Harunobu Tahara, Ryo Inoue, Masakazu Kakuni, Chise Tateno and Junko Ushiki
Drug Metabolism and Disposition March 1, 2012, 40 (3) 474-480; DOI: https://doi.org/10.1124/dmd.111.042754

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

INDUCTION OF CYP3A4 AND CYP2C SUBFAMILIES IN PXB MICE

Maki Hasegawa, Harunobu Tahara, Ryo Inoue, Masakazu Kakuni, Chise Tateno and Junko Ushiki
Drug Metabolism and Disposition March 1, 2012, 40 (3) 474-480; DOI: https://doi.org/10.1124/dmd.111.042754
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro-In Vivo Extrapolation Using Empirical Scaling
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics